These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15756301)

  • 1. A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance.
    Sperandeo MP; Paladino S; Maiuri L; Maroupulos GD; Zurzolo C; Taglialatela M; Andria G; Sebastio G
    Eur J Hum Genet; 2005 May; 13(5):628-34. PubMed ID: 15756301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.
    Torrents D; Estévez R; Pineda M; Fernández E; Lloberas J; Shi YB; Zorzano A; Palacín M
    J Biol Chem; 1998 Dec; 273(49):32437-45. PubMed ID: 9829974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
    Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
    Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
    Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
    Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.
    Rotoli BM; Barilli A; Visigalli R; Ferrari F; Dall'Asta V
    J Cell Mol Med; 2020 Jan; 24(1):921-929. PubMed ID: 31705628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of LPI-causing mutations on y+LAT1 function and localization.
    Rotoli BM; Barilli A; Ingoglia F; Visigalli R; Bianchi MG; Ferrari F; Martinelli D; Dionisi-Vici C; Dall'Asta V
    Orphanet J Rare Dis; 2019 Mar; 14(1):63. PubMed ID: 30832686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.
    Font-Llitjós M; Rodríguez-Santiago B; Espino M; Sillué R; Mañas S; Gómez L; Pérez-Jurado LA; Palacín M; Nunes V
    Eur J Hum Genet; 2009 Jan; 17(1):71-9. PubMed ID: 18716612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.
    Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Kadija Z; Rodi G; Mariani F; Ruzza ML; Luisetti M; Dall'Asta V
    Orphanet J Rare Dis; 2010 Nov; 5():32. PubMed ID: 21110863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene.
    Sperandeo MP; Andria G; Sebastio G
    Hum Mutat; 2008 Jan; 29(1):14-21. PubMed ID: 17764084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene.
    Sperandeo MP; Annunziata P; Ammendola V; Fiorito V; Pepe A; Soldovieri MV; Taglialatela M; Andria G; Sebastio G
    Hum Mutat; 2005 Apr; 25(4):410. PubMed ID: 15776427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance.
    Shoji Y; Noguchi A; Shoji Y; Matsumori M; Takasago Y; Takayanagi M; Yoshida Y; Ihara K; Hara T; Yamaguchi S; Yoshino M; Kaji M; Yamamoto S; Nakai A; Koizumi A; Hokezu Y; Nagamatsu K; Mikami H; Kitajima I; Takada G
    Hum Mutat; 2002 Nov; 20(5):375-81. PubMed ID: 12402335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.
    Borsani G; Bassi MT; Sperandeo MP; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Incerti B; Pepe A; Andria G; Ballabio A; Sebastio G
    Nat Genet; 1999 Mar; 21(3):297-301. PubMed ID: 10080183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of normal and mutant GFP-tagged y(+)L amino acid transporter-1 in mammalian cells.
    Toivonen M; Mykkänen J; Aula P; Simell O; Savontaus ML; Huoponen K
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1173-9. PubMed ID: 11883940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of symptoms and treatment for lysinuric protein intolerance.
    Noguchi A; Takahashi T
    J Hum Genet; 2019 Sep; 64(9):849-858. PubMed ID: 31213652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance.
    Sperandeo MP; Annunziata P; Bozzato A; Piccolo P; Maiuri L; D'Armiento M; Ballabio A; Corso G; Andria G; Borsani G; Sebastio G
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C191-8. PubMed ID: 17376816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter analysis of the human SLC7A7 gene encoding y+L amino acid transporter-1 (y+LAT-1).
    Mykkänen J; Toivonen M; Kleemola M; Savontaus ML; Simell O; Aula P; Huoponen K
    Biochem Biophys Res Commun; 2003 Feb; 301(4):855-61. PubMed ID: 12589791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of SLC7A7 Triggers an Inflammatory Phenotype in Human Macrophages and Airway Epithelial Cells.
    Rotoli BM; Barilli A; Visigalli R; Ingoglia F; Milioli M; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V
    Front Immunol; 2018; 9():508. PubMed ID: 29616026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysinuric protein intolerance: reviewing concepts on a multisystem disease.
    Sebastio G; Sperandeo MP; Andria G
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):54-62. PubMed ID: 21308987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.
    Noguchi A; Shoji Y; Koizumi A; Takahashi T; Matsumori M; Kayo T; Ohata T; Wada Y; Yoshimura I; Maisawa S; Konishi M; Takasago Y; Takada G
    Hum Mutat; 2000; 15(4):367-72. PubMed ID: 10737982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of y+LAT1 and 4F2hc in the y+l amino acid transporter complex: consequences of lysinuric protein intolerance-causing mutations.
    Toivonen M; Tringham M; Kurko J; Terho P; Simell O; Heiskanen KM; Mykkänen J
    Gen Physiol Biophys; 2013 Dec; 32(4):479-88. PubMed ID: 23940088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.